Abstract:Abstract Background Inflammation can induce cognitive dysfunction in patients who undergo surgery. Previous studies have demonstrated that both acute peripheral inflammation and anaesthetic insults, especially isoflurane (ISO), are risk factors for memory impairment. Few studies are currently investigating the role of ISO under acute peri-inflammatory conditions, and it is difficult to predict whether ISO can aggravate inflammation-induced cognitive deficits. HDACs, which are essential for learning, participate in the deacetylation of lysine residues and the regulation of gene transcription. However, the cell-specific mechanism of HDACs in inflammation-induced cognitive impairment remains unknown. Methods Three-month-old C57BL/6 mice were treated with single versus combined exposure to LPS injected intraperitoneally (i.p.) to simulate acute abdominal inflammation and isoflurane to investigate the role of anaesthesia and acute peripheral inflammation in cognitive impairment. Behavioural tests, Western blotting, ELISA, immunofluorescence, qRT-PCR, and ChIP assays were performed to detect memory, the expressions of inflammatory cytokines, HDAC2, BDNF, c-Fos, acetyl-H3, microglial activity, Bdnf mRNA, c-fos mRNA, and Bdnf and c-fos transcription in the hippocampus. Results LPS, but not isoflurane, induced neuroinflammation-induced memory impairment and reduced histone acetylation by upregulating histone deacetylase 2 (HDAC2) in dorsal hippocampal CaMKII + neurons. The hyperexpression of HDAC2 in neurons was mediated by the activation of microglia. The decreased level of histone acetylation suppressed the transcription of Bdnf and c-fos and the expressions of BDNF and c-Fos, which subsequently impaired memory. The adeno-associated virus Sh Hdac2 , which suppresses Hdac2 after injection into the dorsal hippocampus, reversed microglial activation, hippocampal glutamatergic BDNF and c-Fos expressions, and memory deficits. Conclusions Reversing HDAC2 in hippocampal CaMKII + neurons exert a neuroprotective effect against neuroinflammation-induced memory deficits.

Classical HDACs in the Regulation of Neuroinflammation.

Role of histone deacetylases and their inhibitors in neurological diseases

Histone deacetylases and their inhibitors in inflammatory diseases

Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases

Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge

HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases

Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management

Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders

HDAC3 in action: Expanding roles in inflammation and inflammatory diseases.

Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Autophagy in Neuroinflammation: A Focus on Epigenetic Regulation

The role of class IIa histone deacetylases in regulating endothelial function

Molecular targets of histone deacetylase inhibitors in neurodegeneration and neuroprotection

HDACi: molecular mechanisms and therapeutic implications in the innate immune system

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases

The modulatory role of dopamine receptors in brain neuroinflammation

Role of Histone Post-Translational Modifications in Inflammatory Diseases

HDAC2 hyperexpression alters hippocampal neuronal transcription and microglial activity in neuroinflammation-induced cognitive dysfunction

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer's Disease.

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer’s Disease